N2off, INC 8-K filings
NITO
N2off, INCN2OFF, Inc. announces that its subsidiary Save Foods Ltd. has won a patent opposition case against ECOLAB in Europe, potentially strengthening its position in the European market.
NITO
N2off, INCN2OFF, Inc. has received a second 180-day extension from Nasdaq to regain compliance with the minimum $1.00 bid price requirement, extending the deadline to July 7, 2025.
NITO
N2off, INCN2OFF, Inc. finalized a private placement on January 2, 2025, issuing shares and warrants, and raising $1.5 million in gross proceeds.
NITO
N2off, INCN2OFF, Inc. has entered into a $250,000 loan agreement with MitoCareX Bio Ltd., guaranteed by L.I.A. Pure Capital Ltd., and issued 650,000 shares of common stock to its directors.
NITO
N2off, INCN2OFF, Inc. has issued common stock warrants with a floor price of $0.048 to protect against excessive dilution, as part of a previously announced private placement.
NITO
N2off, INCN2OFF, Inc. has entered into a securities purchase agreement for a $1.5 million private placement, issuing common stock, pre-funded warrants, and common warrants, while also settling debt with Plantify Foods, Inc.
NITO
N2off, INCN2OFF Inc. has agreed to settle a debt of CDN$2,052,879.39 with Plantify Foods by receiving 2,420,848 common shares, resulting in a 65.4% ownership stake in Plantify.
NITO
N2off, INCN2OFF, Inc. held its 2024 annual meeting, re-electing directors, increasing shares for the incentive plan, and approving other key proposals, but failing to pass a proposal to increase authorized capital.
NITO
N2off, INCN2OFF, Inc. has amended its bylaws to reduce the quorum requirement for stockholder meetings from a majority to 33.33% of voting power.
NITO
N2off, INC8-K: N2OFF Secures €6 Million Credit Facility, Eyes Strategic Spin-Off and Drug Discovery Acquisition
N2OFF, Inc. has entered into a facility agreement for a €6 million credit line, while also announcing plans for a potential spin-off of its cleantech operations and the acquisition of a drug discovery company.
NITO
N2off, INCN2OFF, Inc. issued a total of 1,740,000 shares of common stock to consultants, officers, and an investor in September 2024.
NITO
N2off, INCN2OFF Inc. and Solterra Renewable Energy Ltd. announced a potential 10% increase in capacity for their solar PV joint venture project due to a larger than expected grid connection approval.
NITO
N2off, INCN2OFF Inc. and Solterra Renewable Energy Ltd. have received approval to connect their first solar PV project in Germany to the power grid, marking a significant milestone for the joint venture.
NITO
N2off, INCN2OFF, Inc. has committed to loan up to 8 million euros for a 50% stake in solar photovoltaic projects developed by Solterra Renewable Energy Ltd., starting with a 2.08 million euro investment in a 111 MWp project in Melz, Germany.
NITO
N2off, INCN2OFF, Inc. received a notice from Nasdaq regarding its failure to maintain a minimum share price of $1.00, placing it at risk of delisting.
NITO
N2off, INC8-K: N2OFF Inc. Stockholders Approve Reverse Stock Split, Reject Capital Increase at Special Meeting
N2OFF Inc. stockholders approved a reverse stock split but rejected a proposal to increase authorized capital at a special meeting held on June 28, 2024.
NITO
N2off, INCN2OFF, Inc. has entered into a $1.5 million promissory note agreement with YA II PN, Ltd., with an initial discount and a repayment schedule starting in June 2024.
NITO
N2off, INCSave Foods, Inc. has rebranded to N2OFF Inc., reflecting a shift towards sustainable environmental solutions, and will trade under the new ticker symbol NITO starting March 19, 2024.
NITO
N2off, INCSave Foods, Inc. announces its subsidiary Nitrousink Ltd. has changed its name to NTWO OFF Ltd., focusing on reducing nitrous oxide emissions in agriculture.
NITO
N2off, INCSave Foods, Inc. plans to distribute its holdings in Plantify Foods, Inc. to its stockholders later in 2024.
NITO
N2off, INCSave Foods, Inc. has received stockholder approval to change its name to N2OFF, Inc. and to issue up to 20% of its shares under a $20 million standby equity purchase agreement.